Introduction
Cyclophosphamide is the most widely used cancer chemotherapeutic agent and is also used as an immunosuppressive agent. It is administered both orally and parenterally over a wide dosage range depending on the therapeutic indications and acceptable adverse effects. The clinical use of cyclophosphamide has been recently reviewed (Hill, 1975; Colvin, 1978) . Cyclophosphamide consists of a nitrogen mustard group (bischloroethylamine) attached to an oxazophosphorine ring. The parent compound is inactive in vitro and is converted to a number of active metabolites by hepatic microsomal enzymes. The kinetics of all the metabolites has not been elucidated because of technical difficulties. However, the pharmacokinetics of the parent compound has been well worked out and confirmed by several workers. The importance of using specific methods, and in particular, gas-liquid chromatography, has been highlighted by van 
Analytical methods
The estimation of cyclophosphamide from biological fluid was accomplished by the method of Juma et al. (1978) which estimates the trifluoroacetyl derivative of cyclophosphamide using a gas-liquid chromatograph fitted with an alkaline flame ionisation detector.
The coefficient of variation within assay was 3.5% (at 10 ,ug/ml) and 4.3% (at 50 ,ug/ml) and between assays was 5.4% (5 /,g/ml) and 5.7% (20 gg/ml). The rest of the pharmacokinetic parameters were derived using standard procedures (Gibaldi & Perrier, 1975) .
Results
The pharmacokinetic data derived from the study of 10 Kenyan Africans is shown in (VI) and the apparent volume of distribution (V) were 0.35 ± 0.12 1/kg and 0.64 ± 0.061 1/kg respectively. These pharmacokinetic parameters are similar to those that have been reported for cyclophosphamide in Caucasians, suggesting that the Kenyan Africans handle cyclophosphamide in a similar fashion.
Discussion
The pharmacokinetic parameters obtained in this study are comparable to the pharmacokinetic parameters of cyclophosphamide that we have reported in Caucasians (Juma et al., 1978 (Juma et al., , 1979 (Juma et al., , 1980 , and to the pharmacokinetics of cyclophosphamide reported by otherworkers (Cohenetal., 1970; Bagley etal., 1973; Jarman et al., 1979 In this study we used a gas-liquid chromatograph fitted with an alkaline flame ionisation detector as detailed by Juma et al. (1978) . The accuracy and convenience of this method has been highlighted by van den Bosch & Vos (1980) . Similar inter-individual variation obtained in this study has been reported by others (Hill, 1975; Mouridsen et al., 1974; Colvin, 1978) , and it probably reflects individual differences in activity of liver microsomal enzymes in the metabolism of cyclophosphamide. Large interindividual variations in drug kinetics can arise from multiple genetic and environmental factors affecting drug absorption, distribution, biotransformation, excretion and interaction with receptor sites, or a combination of these (Vessel, 1978) . Twin and family studies demonstrate that for several commonly used drugs, genetic factors are predominantly responsible for large inter-individual variations in drug disposition that occur in normal volunteers under basal conditions. Environmental factors were surprisingly small. It would therefore be expected that individual variation observed in the pharmacokinetics of cyclophosphamide by different workers and by us are due to other genetic variation other than racial.
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